Recently he has been in the news regarding the Microsoft/Yahoo dispute, but he's still in touch with his BioTech business in San Diego, CA...
NEW YORK - Billionaire investor Carl Icahn on Thursday reported raising his stake in biotech Amylin Pharmaceuticals Inc. and said he is in discussions with management about ways to maximize product sales and development.
According to the filing, Icahn has recently held discussions with the company's management, and plans to have further conversations about ways to enhance shareholder value.
Icahn reports increased stake in Amylin Pharma - News Wires - CNBC.com
0 comments :
Post a Comment